Indonesian Newcastle Disease Virus Field Isolate Reduces c-Jun Expression in Rat Mammary Cancer Models
Downloads
c-Jun is often found to be overexpressed in various cancers, so this gene might be a target for cancer therapy. Newcastle disease virus (NDV) is recognized for its oncolytic properties and potential as a cancer virotherapy agent, with various mechanisms reported to trigger cancer cell death. This study aimed to assess the c-Jun expression in rat mammary cancer models. Rat mammary cancer models were categorized into two treatment groups: the control group (C) and the virotherapy group (V). Group C was administered with 0.5 cc of sterile PBS, while group V received 7 log 2 HAU per 0.5 cc of the Indonesian NDV field isolate Tabanan-1/ARP/2017 intratumorally. The treatment was carried out for four days in a row. Two weeks after treatment, all rats were humanely euthanized, and mammary cancer tissues were excised for further examination. Mammary cancer tissues were examined histopathologically and analyzed using immunohistochemistry to determine intranuclear c-Jun expression, quantified by the H-Score. The results demonstrated that NDV significantly reduced c-Jun expression. It can be inferred that NDV Tabanan-1/ARP/2017 holds potential as a mammary cancer therapy agent by reducing c-Jun expression. This finding is considered novel, as there have been no previous reports of decreased c-Jun expression following virotherapy with NDV.
Adi, A.A.A.M., I.N.M. Astawa, I.N. Wandia, I.G.A.A. Putra, I.B.O. Winaya, A.A.K. Krisnandika, and A.A.O. Wijaya. 2019. Molecular characteristic of avian orthoavulavirus 1 genotype VII isolated from Tabanan Bali. J. Vet., 20(4): 593-602.
Alvarado-Ortiz, E., K.G. de la Cruz-López, J. Becerril-Rico, M.A. Sarabia-Sánchez, E. Ortiz-Sánchez, and A. García-Carrancá. 2021. Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches. Front. Cell Dev. Biol., 8: 607670.
Bahar, M.E., H.J. Kim, and D.R. Kim. 2023. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct. Target. Ther., 8(1): 455.
Binato, R., S. Corrêa, C. Panis, G. Ferreira, I. Petrone, I.R. da Costa, and E. Abdelhay. 2021. NRIP1 is activated by C-JUN/C-FOS and activates the expression of PGR, ESR1, and CCND1 in luminal A breast cancer. Sci. Rep., 11(1): 21159.
Brennan, A., J.T. Leech, N.M. Kad, and J.M. Mason. 2020. Selective antagonism of cJun for cancer therapy. J. Exp. Clin. Cancer Res., 39(1): 184.
Bu, X.F., M.B. Wang, Z.J. Zhang, Y.H. Zhao, M. Li, and Y.L. Yan. 2015. Autophagy is involved in recombinant Newcastle disease virus (rL-RVG)-induced cell death of stomach adenocarcinoma cells in vitro. Int. J. Oncol., 47(2): 679-689.
El Makawy, A.I., D.M. Mabrouk, S.E. Mohammed, S.H. Abdel-Aziem, H.A.A. El-Kader, H.A. Sharaf, and F.M. Ibrahim. 2022. The suppressive role of nanoencapsulated chia oil against DMBA-induced breast cancer through oxidative stress repression and tumor genes expression modulation in rats. Mol. Biol. Rep., 49(11): 10217-10228.
Guo, Y.J., W.W. Pan, S.B. Liu, Z.F. Shen, Y. Xu, and L.L. Hu. 2020. ERK/MAPK signalling pathway and tumorigenesis. Exp. Ther. Med., 19(3): 1997-2007.
Han, Y., S. Katayama, M. Futakuchi, K. Nakamichi, Y. Wakabayashi, M. Sakamoto, and K. Semba. 2023. Targeting c-Jun is a potential therapy for luminal breast cancer bone metastasis. Mol. Cancer Res., 21(9): 908-921.
He, H., I. Sinha, R. Fan, L.A. Haldosen, F. Yan, C. Zhao, and K. Dahlman-Wright. 2018. c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer. Oncogene, 37(19): 2586-2600.
Hochstrasser, M., and D. Kornitzer. 1998. Ubiquitin-dependent degradation of transcription regulators. In J-M. Peters, J.R. Harris and D. Finl;ay (Eds), Ubiquitin and the Biology of the Cell (pp. 279-302). Boston, MA: Springer US.
Joao, A.A.P.D.C., A.A.A.M. Adi, I.N.M. Astawa, R.D. Soejoedono, A.A.K. Krisnandika, and P.S. Sewoyo. 2022. Isolation of Newcastle Disease Virus Genotype VII from Native Chicken in Republic Democratic of Timor-Leste. J. Adv. Vet. Res., 12(3): 248-252.
Kayahara, M., X. Wang, and C. Tournier. 2005. Selective regulation of c-jun gene expression by mitogen-activated protein kinases via the 12-o-tetradecanoylphorbol-13-acetate-responsive element and myocyte enhancer factor 2 binding sites. Mol. Cell. Biol., 25(9):3784–3792.
Leary, S., W. Underwood, R. Anthony, S. Cartner, D. Corey, T. Grandin, and R. Yanong. 2020. AVMA guidelines for the euthanasia of animals 2020 ed. Schaumburg, IL, USA: American Veterinary Medical Association.
Lin, D., Y. Shen, and T. Liang. 2023. Oncolytic virotherapy: basic principles, recent advances, and future directions. Signal Transduct. Target. Ther., 8(1): 156.
Meng, Q., and Y. Xia. 2011. c-Jun, at the crossroad of the signaling network. Protein Cell, 2(11): 889-898.
Pradnyandika, I.P.K.A., I.N.M. Astawa, and A.A.A.M. Adi. 2023. Newcastle Disease Virus as Virotherapy Agent Targeting p53 in Rat Fibrosarcoma Models. J. Adv. Vet. Res., 13(1): 65-69.
Rakhmawati, I., A.A.A.M. Adi, I.B.O. Winaya, and P.S. Sewoyo. 2022. In vivo oncolytic potency of Newcastle disease virus Gianyar-1/ak/2014 virulent strain against mice fibrosarcoma models. Rev. Electrón. Vet., 23(1): 56-63.
Schirrmacher, V. 2022. Molecular mechanisms of anti-neoplastic and immune stimulatory properties of oncolytic Newcastle disease virus. Biomedicines, 10(3): 562.
Sewoyo, P.S. 2024. Ekspresi Ki67 dan VEGF pada Tikus Model Karsinoma Mammae Setelah Diviroterapi dengan Virus Newcastle Disease Isolat Tabanan-1/ARP/2017. Thesis, Fakultas Kedokteran Hewan, Universitas Udayana.
Sewoyo, P.S., A.A.A.M. Adi, I.B.O. Winaya, I.P. Sampurna, and A.A.B. Bramardipa. 2021. The Potency of Virulent Newcastle Disease Virus Tabanan-1/ARP/2017 as Virotherapy Agents in Rat Fibrosarcoma Models. J. Adv. Vet. Res., 11(2): 64-68.
Sewoyo, P.S., I.N.M. Astawa, A.A.A.M. Adi, M.S. Purwitasari, I.N.S.T. Hartaputera, and S. Aisyah. 2024. Newcastle disease virus Tabanan-1/ARP/2017 inhibits growth of rat mammary carcinoma models. J. Adv. Vet. Res., 14(4): 563-566.
Shao, C., Y. Huang, B. Fu, S. Pan, X. Zhao, N. Zhang, and D. Kong. 2021. Targeting c-Jun in A549 cancer cells exhibits antiangiogenic activity in vitro and in vivo through exosome/miRNA-494-3p/PTEN signal pathway. Front. Oncol., 11: 663183.
Solomon, H., S. Madar, and V. Rotter. 2011. Mutant p53 gain of function is interwoven into the hallmarks of cancer. J. Pathol., 225(4): 475-478.
Song, H., L.P. Zhong, J. He, Y. Huang, and Y.X. Zhao. 2019. Application of Newcastle disease virus in the treatment of colorectal cancer. World J. Clin. Cases, 7(16): 2143.
Vleugel, M.M., A.E. Greijer, R. Bos, E. van der Wall, and P.J. van Diest. 2006. c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum. Pathol., 37(6): 668-674.
Wen, Z., D. Luo, S. Wang, R. Rong, B.M. Evers, L. Jia, and G. Xiao. 2024. Deep Learning–Based H-Score Quantification of Immunohistochemistry-Stained Images. Mod. Pathol., 37(2): 100398.
Ye, T., K. Jiang, L. Wei, M.P. Barr, Q. Xu, G. Zhang, and H. Piao. 2018. Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells. Am. J. Cancer Res., 8(8): 1514.
Copyright (c) 2025 Fransiska Gratia Sonita Marson, Palagan Senopati Sewoyo, I Nyoman Mantik Astawa, Anak Agung Ayu Mirah Adi, Ida Bagus Kade Suardana, Ida Bagus Oka Winaya, I Ketut Berata
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Veterinary Medicine Journal by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The Journal allows the author to hold the copyright of the article without restrictions.
2. The Journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
11.jpg)
11.png)
